These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23209232)

  • 1. Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline.
    Hua X; Zhou H; Jiang Y; Feng Y; Chen Q; Ruan Z; Yu Y
    J Bacteriol; 2012 Dec; 194(24):6979-80. PubMed ID: 23209232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
    Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
    Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis.
    Zurawski DV; Thompson MG; McQueary CN; Matalka MN; Sahl JW; Craft DW; Rasko DA
    J Bacteriol; 2012 Mar; 194(6):1619-20. PubMed ID: 22374953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline.
    Wadi JA; Al Rub MA
    Ann Saudi Med; 2007; 27(6):456-8. PubMed ID: 18059130
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
    Salehi B; Goudarzi H; Nikmanesh B; Houri H; Alavi-Moghaddam M; Ghalavand Z
    J Infect Chemother; 2018 Jul; 24(7):515-523. PubMed ID: 29555392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline.
    Kooli I; Brahim HB; Kilani M; Gannouni C; Aouam A; Toumi A; Loussaief C; Hattab MN; Chakroun M
    J Glob Antimicrob Resist; 2016 Jun; 5():62-3. PubMed ID: 27436468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy.
    Hornsey M; Loman N; Wareham DW; Ellington MJ; Pallen MJ; Turton JF; Underwood A; Gaulton T; Thomas CP; Doumith M; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Jul; 66(7):1499-503. PubMed ID: 21565804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Ricciardi R; Ricciardi AM; Danzi G
    Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
    Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
    Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome sequence of Acinetobacter baumannii AC12, a polymyxin-resistant strain isolated from Terengganu, Malaysia.
    Gan HM; Lean SS; Suhaili Z; Thong KL; Yeo CC
    J Bacteriol; 2012 Nov; 194(21):5979-80. PubMed ID: 23045494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Draft genome sequence of a multidrug-resistant OXA-23-producing Acinetobacter baumannii ST191 clinical isolate from China.
    Xu J; Lin W; Xi W; Yao Y
    J Glob Antimicrob Resist; 2017 Sep; 10():8-9. PubMed ID: 28572036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
    Arroyo LA; Mateos I; González V; Aznar J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.
    Baang JH; Axelrod P; Decker BK; Hujer AM; Dash G; Truant AR; Bonomo RA; Fekete T
    Am J Infect Control; 2012 Mar; 40(2):134-7. PubMed ID: 21835501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
    Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline: a new treatment choice against Acinetobacter baumannii.
    Bosó-Ribelles V; Romá-Sánchez E; Carmena J; Cáceres C; Bautista D
    Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):117-22. PubMed ID: 18673124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.